OOIR: Observatory of International Research

Papers

(The H4-Index of Rheumatology is 44. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)

Article	Citations
Treatment guidelines in psoriatic arthritis	108
Baricitinib improves respiratory function in patients treated with corticosteroids for SARS-CoV-2 pneumonia: an observational cohort study	97
Herpes zoster following BNT162b2 mRNA COVID-19 vaccination in patients with autoimmune inflammatory rheumatic diseases: a case series	97
Lupus nephritis: clinical presentations and outcomes in the 21st century	95
Incidence and severeness of COVID-19 hospitalization in patients with inflammatory rheumatic disease: a nationwide cohort study from Denmark	92
Osteosarcopenia: where osteoporosis and sarcopenia collide	87
COVID-19 vaccination and antirheumatic therapy	86
IgG4-related disease: a clinical perspective	79
Efficacy of plasma exchange in anti-MDA5-positive dermatomyositis with interstitial lung disease under combined immunosuppressive treatment	78
The genetics of rheumatoid arthritis	75
Long-term outcomes in systemic lupus erythematosus: trends over time and major contributors	75
Difficult-to-treat rheumatoid arthritis: contributing factors and burden of disease	71
Diagnostic delay in axial spondyloarthritis: a systematic review and meta-analysis	69
A roadmap to target interleukin-6 in osteoarthritis	68
Treating systemic lupus erythematosus in the 21st century: new drugs and new perspectives on old drugs	68
An update on the epidemiology of ANCA-associated vasculitis	68
A systematic review and meta-analysis to inform cancer screening guidelines in idiopathic inflammatory myopathies	64
Behçet: the syndrome	64
Abatacept in interstitial lung disease associated with rheumatoid arthritis: national multicenter study of 263 patients	63
VEXAS syndrome in a woman	62
Genetics and epigenetics in primary Sjögren’s syndrome	59
Rituximab in the treatment of systemic sclerosis–related interstitial lung disease: a systematic review and meta-analysis	59
Prevalence and impact of comorbidities in axial spondyloarthritis: systematic review and meta-analysis	59
The safety of JAK-1 inhibitors	58
Diagnosis of giant cell arteritis	57

Incidence and prevalence of systemic sclerosis globally: a comprehensive systematic review and meta-analysis	55
Prognostic values of anti-Ro52 antibodies in anti-MDA5-positive clinically amyopathic dermatomyositis associated with interstitial lung disease	55
Classification vs diagnostic criteria: the challenge of diagnosing axial spondyloarthritis	54
Sex and gender differences in axial spondyloarthritis: myths and truths	54
Telemedicine in rheumatology: a reliable approach beyond the pandemic	53
Eosinophilic granulomatosis with polyangiitis: understanding the disease and its management	51
The role of chest CT in deciphering interstitial lung involvement: systemic sclerosis versus COVID-19	50
Global, regional, and national burden of other musculoskeletal disorders 1990–2017: results from the Global Burden of Disease Study 2017	50
The management of neuropsychiatric lupus in the 21st century: still so many unmet needs?	50
Mortality, causes of death and influence of medication use in patients with systemic lupus erythematosus vs matched controls	50
Treatment of Sjögren’s syndrome: current therapy and future directions	50
Classifying and diagnosing systemic lupus erythematosus in the 21st century	49
Clinical and imaging characteristics of osteitis condensans ilii as compared with axial spondyloarthritis	49
Is fibromyalgia associated with a unique cytokine profile? A systematic review and meta-analysis	49
Phase 2, randomized, placebo-controlled trial of dapirolizumab pegol in patients with moderate-to-severe active systemic lupus erythematosus	46
Clinical phenotypes of IgG4-related disease reflect different prognostic outcomes	45
Correlation between pain severity and levels of anxiety and depression in osteoarthritis patients: a systematic review and meta-analysis	45
JAK inhibitors are effective in a subset of patients with juvenile dermatomyositis: a monocentric retrospective study	45
Methotrexate and risk of interstitial lung disease and respiratory failure in rheumatoid arthritis: a nationwide population-based study	44
A case of psoriatic arthritis triggered by SARS-CoV-2 infection	44